Prostate cancer is a major cause of cancer morbidity and mortality. Intra-prostatic inflammation is a risk factor for prostate carcinogenesis, with diet, chemical injury and an altered microbiome being causally implicated. Intra-prostatic inflammatory cell recruitment and expansion can ultimately promote ...
SternbergC.N.ingentaconnectCritical Reviews in Oncology Hemetology↵ Sternberg CN. Overview of international collaborative group prostate cancer trials. Crit Rev Oncol Hematol 2002 ; 43 : 153 –158.Sternberg C: Overview of international collaborative group prostate cancer trials. Crit Rev Oncol ...
Cancer Horizons Clinical Trial Corner Heal® Publications Videos Cancer Type Prostate Cancer Treatment and Symptom Management: Episode7 Video September 18, 2015 Your browser does not support the video tag. Related Videos Using Clinical Trials to Advance Prostate Cancer Treatments ...
being tested for prostate cancer overall. For example: ‘I tried not to think about the PSA blood test’ (time-point 1); ‘I tried not to think about going for my biopsy’ (time-point 2); ‘I tried not to think about getting my biopsy results’ (time-point 3) and ‘I tried not...
Table 1. Results of Randomized Clinical Trials of PSA-Based Screening (Key Question 1)a View LargeDownload Table 2. Prostate Cancer and All-Cause Mortality With Radical Prostatectomy or Radiation Therapy (Intervention) Compared With Conservative Management (Control) (Key Question 3)a View LargeDownlo...
2022, Clinical Journal of Oncology Nursing Factors influencing the translation of shared cancer follow-up care into clinical practice: a systematic review View Abstract The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Genetic testing, to identify pathogenic or likely pathogenic variants in prostate cancer, is valuable in guiding treatment decisions for men with prostate cancer and to inform cancer prevention and early detection options for their immediate blood relati
Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa). The IMPACT study is evaluating PSA screening in men with a known genetic predisposition to PrCa due to BRCA1/2 mutations. This analysis evaluates the utility of PSA an...